USE OF AKT3 NUCLEIC ACIDS FOR THE MANUFACTURE OF A MEDICAMENT FOR INHIBITING CELL DEATH, TREATING MYOCARDIAL INFARCTION OR ISCHEMIA REPERFUSION INJURY

• 收藏
• 分享

专利权人:

AVENTIS PHARMACEUTICALS INC.

发明人:

申请号：

IL19027008

公开号：

IL190270A

申请日:

2008.03.18

申请国别(地区):

IL

年份:

2012

代理人:

摘要：

The present invention relates to human Akt3 proteins and polypeptides. The invention also relates to isolated nucleic acids encoding human Akt3, to vectors containing them and to their therapeutic uses, in particular for gene therapy. Expression of Akt3 inhibits cell death associated with hypoxia, apoptosis or necrosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/